Analyses estimating program costs collected on a subsample of facilities are subject to statistical uncertainty, often quantified via standard errors and/or 95% confidence intervals. This recent publication elaborates methods to reduce statistical uncertainty.
Local engagement and empowerment have been essential for the DOVE study to develop cost of illness estimates and apply them to policymaking and program planning in Uganda. Here are some ideas and tools you can use...
Three modules were published from TVEE's vaccine economics curriculum, available to the public for free, on the JHSPH OpenCourseWare (OCW). Anybody can now download lecture slides, syllabi and exercises from this curriculum. Read more here
Catalyst funding is available to support scientists in bacterial vaccinology to explore new approaches and strategies to advance their vaccines in partnership with LMICs and across the academia/industry divide. Read more here.
Recent study estimate cost drivers and unit costs of Immunization and other essential services package in Bangladesh. Supplemented with epidemiological and demographical data, this information could be used to help with policy and decision making. Read more here
Fifth Advanced Course on Health Financing for Universal Coverage for LMIC, to be held from 18 to 22 June 2018 in Tunis, Tunisia. Apply by Thursday 1 March 2018 at midnight (Geneva, Switzerland time). Read more here
A new analysis of health and household economic impact of 10 vaccine antigens across income quintiles for 41 low- and middle-income countries indicates predominant benefit in lowest quintiles, improving health equity. Read more here.
A new publication explains main challenges that countries and donors face in achieving smooth transitions, points to the key strategies and tools that should be used and outlines a recommended agenda for priority research in this area. Read more here.
Benin’s commitment to immunization continues to grow, though sustainability of financing remains a concern. Comparisons with neighboring countries reveal potential lessons for Benin, around efficiency and sustainability. Read more here.
Help ministries of health and UNICEF partners engage effectively with the private providers/sectors to expand immunization coverage and reduce inequities. Proposal deadline Feb 19, (11am Amman time). Read more here.
The workshops series in Jaipur, Karachi, and Kampala focuses on capacity building in applied vaccine economics and financing. Read more here
For Gavi transitioning countries, the LNCT platform offers the opportunity to share transition planning and implementation experience, work together to solve common problems, and add to a global knowledge base of tools and approaches that contribute to successful transition. Learn more about the LNCT platform here
Costs incurred by health programs for activities conducted above the front-line facility or community setting, referred to in this report as costs above the point of service delivery (ASD), constitute a substantial share of health program spending. This landscape summarizes the current state of knowledge and avenues for future inquiry and development. Read more here
Over the 5-year period ending in 2018, 16 countries with a combined birth cohort of over 6 million infants requiring life-saving immunizations are scheduled to transition (graduate) from outside financial and technical support for a number of their essential vaccines. Read more about early experiences from GAVI graduating countries here
This short report revealed community members' demographics, location and area of work, the projects they work on, the identified public resource, and current needs in methodological guide.
In the October 2017 Newsletter Issue, Dr. Brenzel thanks and welcomes the members of the Immunization Economics Community of Practice. Read her welcome letter here.
Dr Orin Levine: "Virtually every child in the world can access a Coca-Cola, yet globally, one in every seven children is still excluded from vaccines. In Africa, one in five go unvaccinated." Read more here
TVEE launched the first workshops of the series in Johannesburg, South Africa and Kampala, Uganda. The workshop series focuses on capacity building in applied vaccine economics, cost-effectiveness and finance. Read more here.
Using a standardised micro-costing tool, a new study presents the cost drivers of HPV vaccine delivery in low income countries and identifies optimal strategies to reduce costs without adversely impacting coverage. Read more here.